{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:30:59Z","timestamp":1790692259741,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation regional fund project of China","award":["82460475"],"award-info":[{"award-number":["82460475"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality globally. Long non-coding RNAs (lncRNAs) are increasingly recognized for their pivotal roles in hepatocarcinogenesis. Specifically, the lncRNA LL22NC03-N14H11.1 (hereafter referred to as LL22NC03) has been characterized as a potent oncogenic factor in certain cancers. Therefore, our research aimed to investigate the involvement of LL22NC03 in HCC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the expression of IGF2BP3 in HCC specimens obtained from The Cancer Genome Atlas (TCGA) dataset. Further investigation via RNA pull-down and mass spectrometry analysis identified LL22NC03 as a binding partner of IGF2BP3, with LL22NC03 enhancing the stability of IGF2BP3 by inhibiting TRIM25-mediated ubiquitination. Subsequent in vitro and in vivo experiments were conducted to explore the modulation of LL22NC03 expression, in combination with manipulation of IGF2BP3 levels, which significantly impacted glycolysis, proliferation, migration, and invasiveness of HCC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study identified LL22NC03 as a promoter of HCC proliferation and migration of HCC cells. LL22NC03 was observed to bind to the ubiquitination site of IGF2BP3, thereby preventing its degradation and enhancing its stability. This interaction ultimately inhibited the degradation of IGF2BP3. Additionally, the interaction between LL22NC03 and IGF2BP3 facilitated the transcription of MYC, leading to the upregulation of glycolytic genes, including HK2, LDHA, GLUT1, PKM2, and PDK1. Finally, IGF2BP3 played a role in stabilizing MYC by recognizing N6-methyladenosine (m6A) modifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The LL22NC03-IGF2BP3-MYC regulatory axis is critically involved in the progression of HCC, suggesting its potential as a novel therapeutic target for this malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03606-1","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:37:50Z","timestamp":1764653870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation"],"prefix":"10.1186","volume":"45","author":[{"given":"Tingzhuang","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meini","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengchong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"2","key":"3606_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42(2):180\u201397.","journal-title":"Cancer Cell"},{"issue":"1","key":"3606_CR2","volume":"1873","author":"D Anwanwan","year":"2020","unstructured":"Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta. 2020;1873(1):188314.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3606_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","volume":"164","author":"J Wang","year":"2023","unstructured":"Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, et al. N6-methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells\u2019 properties and lenvatinib resistance through WNT\/\u03b2-catenin and hippo signaling pathways. Gastroenterology. 2023;164(6):990\u20131005.","journal-title":"Gastroenterology"},{"issue":"4","key":"3606_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3(4):386\u2013401.","journal-title":"Nat Cancer"},{"key":"3606_CR5","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.2147\/OTT.S217468","volume":"12","author":"CC Cheng","year":"2019","unstructured":"Cheng CC, Chao WT, Liao CC, Shih JH, Lai YS, Hsu YH, et al. The roles of angiogenesis and cancer stem cells in sorafenib drug resistance in hepatocellular carcinoma. Onco Targets Ther. 2019;12:8217\u201327.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3606_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-019-0669-z","volume":"11","author":"JJ de Jong","year":"2019","unstructured":"de Jong JJ, Liu Y, Robertson AG, Seiler R, Groeneveld CS, van der Heijden MS, et al. Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome Med. 2019;11(1):60.","journal-title":"Genome Med"},{"issue":"19","key":"3606_CR7","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1093\/nar\/gky696","volume":"46","author":"Q Sun","year":"2018","unstructured":"Sun Q, Tripathi V, Yoon JH, Singh DK, Hao Q, Min KW, et al. MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs. Nucleic Acids Res. 2018;46(19):10405\u201316.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"3606_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2584-z","volume":"11","author":"T Yi","year":"2020","unstructured":"Yi T, Luo H, Qin F, Jiang Q, He S, Wang T, et al. LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission. Cell Death Dis. 2020;11(10):832.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3606_CR9","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41467-019-09769-8","volume":"10","author":"T Schneider","year":"2019","unstructured":"Schneider T, Hung LH, Aziz M, Wilmen A, Thaum S, Wagner J, et al. Combinatorial recognition of clustered RNA elements by the multidomain RNA-binding protein IMP3. Nat Commun. 2019;10(1):2266.","journal-title":"Nat Commun"},{"issue":"1","key":"3606_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/hep.27380","volume":"61","author":"S Sen","year":"2015","unstructured":"Sen S, Langiewicz M, Jumaa H, Webster NJ. Deletion of serine\/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice. Hepatology. 2015;61(1):171\u201383.","journal-title":"Hepatology"},{"issue":"28","key":"3606_CR11","doi-asserted-by":"publisher","first-page":"25149","DOI":"10.18632\/oncotarget.4438","volume":"6","author":"M Li","year":"2015","unstructured":"Li M, Zhang L, Ge C, Chen L, Fang T, Li H, et al. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma. Oncotarget. 2015;6(28):25149\u201360.","journal-title":"Oncotarget"},{"issue":"25","key":"3606_CR12","doi-asserted-by":"publisher","first-page":"40469","DOI":"10.18632\/oncotarget.17118","volume":"8","author":"S Bhargava","year":"2017","unstructured":"Bhargava S, Visvanathan A, Patil V, Kumar A, Kesari S, Das S, et al. IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA\/p65. Oncotarget. 2017;8(25):40469\u201385.","journal-title":"Oncotarget"},{"issue":"5","key":"3606_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-022-04950-2","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, He H, Zhang F, Hu X, Bi F, Li K, et al. M6A methylated EphA2 and VEGFA through IGF2BP2\/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K\/AKT and ERK1\/2 signaling. Cell Death Dis. 2022;13(5):483.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3606_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/oxygen2030022","volume":"2","author":"S Yoshikawa","year":"2022","unstructured":"Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Matsuda S. Roles of reactive oxygen species and autophagy in the pathogenesis of Cisplatin-induced acute kidney injury. Oxygen. 2022;2(3):317\u201326.","journal-title":"Oxygen"},{"issue":"1","key":"3606_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21(1):60.","journal-title":"Mol Cancer"},{"issue":"14","key":"3606_CR16","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.7150\/thno.74600","volume":"12","author":"B Li","year":"2022","unstructured":"Li B, Zhao R, Qiu W, Pan Z, Zhao S, Qi Y, et al. The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. Theranostics. 2022;12(14):6363\u201379.","journal-title":"Theranostics"},{"issue":"6","key":"3606_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"issue":"2","key":"3606_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2009.10.026","volume":"52","author":"B Terris","year":"2010","unstructured":"Terris B, Cavard C, Perret C. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. J Hepatol. 2010;52(2):280\u20131.","journal-title":"J Hepatol"},{"issue":"3","key":"3606_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","volume":"136","author":"T Yamashita","year":"2009","unstructured":"Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features. Gastroenterology. 2009;136(3):1012\u201324.","journal-title":"Gastroenterology"},{"issue":"1","key":"3606_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. CircNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12(1):295.","journal-title":"Nat Commun"},{"issue":"1","key":"3606_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12967-023-04235-y","volume":"21","author":"F Yang","year":"2023","unstructured":"Yang F, Ma Q, Huang B, Wang X, Pan X, Yu T, et al. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. J Transl Med. 2023;21(1):402.","journal-title":"J Transl Med"},{"issue":"9","key":"3606_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70024","volume":"14","author":"S Han","year":"2024","unstructured":"Han S, Guo J, Kong C, Li J, Lin F, Zhu J, et al. ANKRD1 aggravates renal ischaemia-reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3. Clin Transl Med. 2024;14(9):e70024.","journal-title":"Clin Transl Med"},{"issue":"3","key":"3606_CR23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.immuni.2018.08.014","volume":"49","author":"H Lian","year":"2018","unstructured":"Lian H, Zang R, Wei J, Ye W, Hu MM, Chen YD, et al. The zinc-finger protein ZCCHC3 binds RNA and facilitates viral RNA sensing and activation of the RIG-I-like receptors. Immunity. 2018;49(3):438-48.e5.","journal-title":"Immunity"},{"issue":"3","key":"3606_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113945","volume":"43","author":"F Zhang","year":"2024","unstructured":"Zhang F, Liu S, Qiao Z, Li L, Han Y, Sun J, et al. Housekeeping U1 snRNA facilitates antiviral innate immunity by promoting TRIM25-mediated RIG-I activation. Cell Rep. 2024;43(3):113945.","journal-title":"Cell Rep"},{"issue":"720","key":"3606_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720):eadg3049.","journal-title":"Sci Transl Med"},{"issue":"10","key":"3606_CR26","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1038\/s41418-021-00790-3","volume":"28","author":"P Mei","year":"2021","unstructured":"Mei P, Xie F, Pan J, Wang S, Gao W, Ge R, et al. E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis. Cell Death Differ. 2021;28(10):2888\u201399.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3606_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","volume":"22","author":"SW Yue","year":"2023","unstructured":"Yue SW, Liu HL, Su HF, Luo C, Liang HF, Zhang BX, et al. M6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol Cancer. 2023;22(1):137.","journal-title":"Mol Cancer"},{"key":"3606_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116330","author":"G Sharma","year":"2025","unstructured":"Sharma G, Gutierrez M, Jones AE, Kapoor S, Jaiswal AK, Neeb ZT, et al. IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation. Cell Rep. 2025. https:\/\/doi.org\/10.1016\/j.celrep.2025.116330.","journal-title":"Cell Rep"},{"issue":"3","key":"3606_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"3606_CR30","first-page":"4479","volume":"45","author":"T Hu","year":"2017","unstructured":"Hu T, Pi W, Zhu X, Yu M, Ha H, Shi H, et al. Long non-coding RNAs transcribed by ERV-9 LTR retrotransposon act in cis to modulate long-range LTR enhancer function. Nucleic Acids Res. 2017;45(8):4479\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3606_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2017.04.009","volume":"67","author":"M Klingenberg","year":"2017","unstructured":"Klingenberg M, Matsuda A, Diederichs S, Patel T. Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67(3):603\u201318.","journal-title":"J Hepatol"},{"issue":"10","key":"3606_CR32","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1136\/gutjnl-2021-325109","volume":"71","author":"JN S\u00f8ndergaard","year":"2022","unstructured":"S\u00f8ndergaard JN, Sommerauer C, Atanasoai I, Hinte LC, Geng K, Guiducci G, et al. CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut. 2022;71(10):2081\u201392.","journal-title":"Gut"},{"issue":"5","key":"3606_CR33","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jhep.2020.05.028","volume":"73","author":"Y Pang","year":"2020","unstructured":"Pang Y, Liu Z, Han H, Wang B, Li W, Mao C, et al. Peptide SMIM30 promotes HCC development by inducing SRC\/YES1 membrane anchoring and MAPK pathway activation. J Hepatol. 2020;73(5):1155\u201369.","journal-title":"J Hepatol"},{"issue":"8","key":"3606_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s42255-022-00616-7","volume":"4","author":"F Liu","year":"2022","unstructured":"Liu F, Tian T, Zhang Z, Xie S, Yang J, Zhu L, et al. Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma. Nat Metab. 2022;4(8):1022\u201340.","journal-title":"Nat Metab"},{"issue":"1","key":"3606_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-021-01485-6","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 2022;21(1):16.","journal-title":"Mol Cancer"},{"issue":"10","key":"3606_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1457","volume":"13","author":"X Sun","year":"2023","unstructured":"Sun X, Ye G, Li J, Shou H, Bai G, Zhang J. Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer. Clin Transl Med. 2023;13(10):e1457.","journal-title":"Clin Transl Med"},{"key":"3606_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110408","volume":"374","author":"Z Gui","year":"2023","unstructured":"Gui Z, Li J, Li J, Li X, Chen L, Ma Z, et al. Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1\/S phase arrest in colorectal cancer cells. Chem Biol Interact. 2023;374:110408.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"3606_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12967-023-04791-3","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, Han Z, Zhang L, Gao C, Wei J, Yang X, et al. Timeless promotes reprogramming of glucose metabolism in oral squamous cell carcinoma. J Transl Med. 2024;22(1):21.","journal-title":"J Transl Med"},{"issue":"3","key":"3606_CR39","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/ptr.8115","volume":"38","author":"Y Park","year":"2024","unstructured":"Park Y, Lee HJ, Sim DY, Park JE, Ahn CH, Park SY, et al. Inhibition of glycolysis and SIRT1\/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells. Phytother Res. 2024;38(3):1235\u201344.","journal-title":"Phytother Res"},{"issue":"3","key":"3606_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.167011","volume":"1870","author":"S Gao","year":"2024","unstructured":"Gao S, Wang Y, Xu Y, Liu L, Liu S. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis. Biochim Biophys Acta. 2024;1870(3):167011.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3606_CR41","first-page":"240","volume":"22","author":"Y Fu","year":"2020","unstructured":"Fu Y, Wang D, Wang H, Cai M, Li C, Zhang X, et al. TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma. Neuro Oncol. 2020;22(2):240\u201352.","journal-title":"Neuro Oncol"},{"issue":"1","key":"3606_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39(1):126.","journal-title":"J Exp Clin Cancer Res"},{"key":"3606_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","volume":"29","author":"M Lederer","year":"2014","unstructured":"Lederer M, Bley N, Schleifer C, H\u00fcttelmaier S. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. Semin Cancer Biol. 2014;29:3\u201312.","journal-title":"Semin Cancer Biol"},{"key":"3606_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-02020-w","author":"K Lin","year":"2024","unstructured":"Lin K, Lin X, Luo F. IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion. Apoptosis. 2024;29(11-12):2147\u201360. https:\/\/doi.org\/10.1007\/s10495-024-02020-w.","journal-title":"Apoptosis"},{"key":"3606_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115288","volume":"263","author":"X Meng","year":"2023","unstructured":"Meng X, Li W, Wu Q, Gao Y, Zhang L. Microcystin-LR induces lactate production disruption via altering the m(6)A modification in Sertoli cells. Ecotoxicol Environ Saf. 2023;263:115288.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"3606_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41420-022-00844-6","volume":"8","author":"M Du","year":"2022","unstructured":"Du M, Peng Y, Li Y, Sun W, Zhu H, Wu J, et al. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma. Cell Death Discov. 2022;8(1):53.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3606_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41417-022-00526-6","volume":"30","author":"Y Cui","year":"2023","unstructured":"Cui Y, Liu J, Liu L, Ma X, Gui Y, Liu H, et al. M(6)A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis. Cancer Gene Ther. 2023;30(1):163\u201371.","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"3606_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06564-2","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang B, Wang B, Ma J, He JJ, Wang ZH, Li Q, et al. LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination. Cell Death Dis. 2024;15(4):242.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3606_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10120-023-01437-7","volume":"27","author":"R Xie","year":"2024","unstructured":"Xie R, Liu L, Lu X, He C, Yao H, Li G. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Gastric Cancer. 2024;27(1):49\u201371.","journal-title":"Gastric Cancer"},{"issue":"1","key":"3606_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.97.1.228","volume":"97","author":"Y Shou","year":"2000","unstructured":"Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A, et al. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc Natl Acad Sci USA. 2000;97(1):228\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"3606_CR51","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479\u201383.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3606_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13046-022-02412-3","volume":"41","author":"Z Jing","year":"2022","unstructured":"Jing Z, Liu Q, He X, Jia Z, Xu Z, Yang B, et al. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer. J Exp Clin Cancer Res. 2022;41(1):198.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3606_CR53","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41467-019-11662-3","volume":"10","author":"Y Fang","year":"2019","unstructured":"Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, et al. CD36 inhibits \u03b2-catenin\/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019;10(1):3981.","journal-title":"Nat Commun"},{"issue":"1","key":"3606_CR54","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","volume":"10","author":"J Tang","year":"2019","unstructured":"Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019;10(1):3499.","journal-title":"Nat Commun"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03606-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:02:39Z","timestamp":1768845759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03606-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3606"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03606-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments in this study were approved by the Animal Ethics Committee of the Affiliated Hospital of Youjiang Medical University for Nationalities (No. U23090726), and the clinical investigations involving human participants were approved by the Medical Ethics Committee of Yichang Central People\u2019s Hospital (IRB No. 2025\u2013474-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its publication in this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}